Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.9611.0922.7930.42-2.27

What is the latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS is 13.96 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.96
Mar202311.09
Mar202222.79
Mar202130.42
Mar2020-2.27

How is EV/Core EBITDA of BAFNA PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 13.96
25.88
Mar2023 11.09
-51.34
Mar2022 22.79
-25.08
Mar2021 30.42
Positive
Mar2020 -2.27 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹176.6 Cr -2.7% -0.5% -27.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,588.0 Cr -7.3% 1.1% 15.2% Stock Analytics
DIVIS LABORATORIES ₹157,711.0 Cr -3.5% 12.9% 53.4% Stock Analytics
CIPLA ₹122,115.0 Cr 0.1% 9.2% 6.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,589.0 Cr -1% 0.2% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,746.6 Cr 3.1% 9.8% -7.6% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-2.7%

-0.5%

-27.2%

SENSEX

2%

9.4%

11.6%


You may also like the below Video Courses